Company: GCTS
Filing Date: 2025-04-01
Form Type: S-3
Source: 0000950170-25-048684
Chunk: 23

Company: GCT Semiconductor Holding, Inc.
Filing Date: 2025-04-01
Form: S-3
Chunk 23
---
,000,000 from time to time through or to our sales agents under this prospectus, as sales agents or as principal. Sales of our Common Stock, if any, under this prospectus will be made by any method that is deemed to be an “at the market offering” as defined in Rule 415(a)(4) under the Securities Act of 1933, as amended (the “Securities Act”). Our Common Stock is listed on The New York Stock Exchange (“NYSE”) under the symbol “GCTS.” The last reported sale price of our Common Stock on The NYSE on March 28, 2025 was $1.78 per share. The compensation of our sales agents for sales of Common Stock pursuant to the sales agreement shall be a commission rate equal to 3.0% of the gross proceeds from each sale. The net proceeds from any sale under this prospectus will be used as described under “Use of Proceeds” in this prospectus. There is no arrangement for funds to be received in escrow, trust or similar arrangement. In connection with the sale of the Common Stock on our behalf, each sales agent will be deemed to be an “underwriter” within the meaning of the Securities Act, and the compensation of the sales agents will be deemed to be underwriting commissions or discounts. We have also agreed to provide indemnification and contribution to the sales agents with respect to certain civil liabilities, including liabilities under the Securities Act. See “ Plan of Distribution .” The sales agents are not required to sell any specific number or dollar amount of Common Stock but will use their commercially reasonable efforts, as our agents and subject to the terms of the sales agreement, to sell the Common Stock offered, as instructed by us. The offering of Common Stock pursuant to this prospectus will terminate upon the earlier of (i) the sale of all Common Stock subject to this prospectus or (ii) the termination of the sales agreement by us or by the sales agents pursuant to the terms of the sales agreement. We are an “emerging growth company” under federal securities laws and are subject to reduced public company reporting requirements. Investing in our common stock involves a high degree of risk. See “Risk Factors” beginning on page 4 of this prospectus and the “Risk Factors” section contained in our reports filed with the Securities and Exchange Commission which are incorporated by reference herein for a discussion of information that should be considered in connection with an investment in our Common Stock. Neither the Securities and Exchange Commission nor any state securities commission